Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan · Delayed Price · Currency is TWD 17.00
+0.20 (1.19%)
Aug 19, 2026, 9:38 AM CST
Welgene Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 398.92 | 375.94 | 322.55 | 280.55 | 321.9 | 312.65 |
Revenue Growth | 15.25% | 16.55% | 14.97% | -12.85% | 2.96% | -21.46% |
Gross Profit Gross Profit Growth | 166.87 | 156.18 | 135.84 | 119.72 | 141.8 | 133.27 |
Operating Income Operating Income Growth | -2.49 | 0.13 | -0.85 | -4.26 | 17.29 | 14.3 |
Net Income Net Income Growth | -1.64 | 1.33 | 1.11 | -2.65 | 9.55 | 13.7 |
Earnings Per Share EPS Growth | -0.07 | 0.06 | 0.05 | -0.11 | 0.41 | 0.59 |
EPS Growth | - | 20.14% | - | - | -30.53% | -58.74% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biotechnology Testing Department Biotechnology Testing Department Growth | 306.99 | 243.4 | 213.64 | 242.01 | 228.89 |
Instrument Sales Department Instrument Sales Department Growth | 68.95 | 79.15 | 66.91 | 79.89 | 83.76 |
Total Total Growth | 375.94 | 322.55 | 280.55 | 321.9 | 312.65 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 201.29 | 267.33 | 226.5 | 197.13 | 217.59 | 223.49 |
Total Debt Total Debt Growth | 249.85 | 226.03 | 129.83 | 154.35 | 51.19 | 23.84 |
Net Cash (Debt) Net Cash Growth | -48.56 | 41.31 | 96.66 | 42.78 | 166.4 | 199.64 |
Net Cash Growth | - | -57.27% | 125.94% | -74.29% | -16.65% | 31.38% |
Net Cash Per Share Net Cash Per Share Growth | -2.05 | 1.77 | 4.15 | 1.84 | 7.13 | 8.64 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 29.09 | 35.27 | 56.08 | -0.37 | 51.43 | 11.25 |
Capital Expenditures CapEx Growth | -131.51 | -41.34 | -4.81 | -27.73 | -26.86 | -4.38 |
Free Cash Flow Free Cash Flow Growth | -102.42 | -6.08 | 51.27 | -28.1 | 24.57 | 6.87 |
Free Cash Flow Growth | - | - | - | - | 257.63% | -80.84% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.83% | 41.54% | 42.11% | 42.67% | 44.05% | 42.63% |
Operating Margin | -0.62% | 0.03% | -0.27% | -1.52% | 5.37% | 4.57% |
Pretax Margin | -0.37% | 0.36% | 0.39% | -1.08% | 4.21% | 5.31% |
Profit Margin | -0.41% | 0.35% | 0.34% | -0.94% | 2.97% | 4.38% |
FCF Margin | -25.67% | -1.62% | 15.90% | -10.02% | 7.63% | 2.20% |
| Fiscal Year | FY 2022 | FY 2021 |
|---|---|---|
| Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.180 | 0.480 |
Dividend Per Share Growth | -62.50% | -56.44% |
Dividend Yield | 0.82% | 2.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 325.91 | 501.03 | - | 54.16 | 41.58 |
Forward PE | - | 18.50 | 18.50 | 18.50 | 18.50 | 18.50 |
P/FCF Ratio | - | - | 10.82 | - | 21.06 | 82.94 |
PS Ratio | 0.98 | 1.15 | 1.72 | 1.86 | 1.61 | 1.82 |